nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextroamphetamine—Sudden death—Teniposide—lymphatic system cancer	0.0348	0.0348	CcSEcCtD
Dextroamphetamine—Digestion impaired—Fludarabine—lymphatic system cancer	0.0234	0.0234	CcSEcCtD
Dextroamphetamine—Stomach ache—Mitoxantrone—lymphatic system cancer	0.0219	0.0219	CcSEcCtD
Dextroamphetamine—Cardiomyopathy—Mitoxantrone—lymphatic system cancer	0.0182	0.0182	CcSEcCtD
Dextroamphetamine—Sudden death—Mitoxantrone—lymphatic system cancer	0.0182	0.0182	CcSEcCtD
Dextroamphetamine—Depression—Mechlorethamine—lymphatic system cancer	0.0135	0.0135	CcSEcCtD
Dextroamphetamine—Speech disorder—Carmustine—lymphatic system cancer	0.0116	0.0116	CcSEcCtD
Dextroamphetamine—Cerebrovascular accident—Fludarabine—lymphatic system cancer	0.0116	0.0116	CcSEcCtD
Dextroamphetamine—Erythema multiforme—Mechlorethamine—lymphatic system cancer	0.0115	0.0115	CcSEcCtD
Dextroamphetamine—Accidental injury—Carmustine—lymphatic system cancer	0.0113	0.0113	CcSEcCtD
Dextroamphetamine—Viral infection—Mitoxantrone—lymphatic system cancer	0.0103	0.0103	CcSEcCtD
Dextroamphetamine—Toxic epidermal necrolysis—Fludarabine—lymphatic system cancer	0.0102	0.0102	CcSEcCtD
Dextroamphetamine—Sweating—Teniposide—lymphatic system cancer	0.00954	0.00954	CcSEcCtD
Dextroamphetamine—Sudden death—Methotrexate—lymphatic system cancer	0.00906	0.00906	CcSEcCtD
Dextroamphetamine—Injury—Bleomycin—lymphatic system cancer	0.00905	0.00905	CcSEcCtD
Dextroamphetamine—Stevens-Johnson syndrome—Fludarabine—lymphatic system cancer	0.00867	0.00867	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Fludarabine—lymphatic system cancer	0.00862	0.00862	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.00861	0.00861	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Fludarabine—lymphatic system cancer	0.00857	0.00857	CcSEcCtD
Dextroamphetamine—Infection—Mechlorethamine—lymphatic system cancer	0.00855	0.00855	CcSEcCtD
Dextroamphetamine—Urinary tract infection—Fludarabine—lymphatic system cancer	0.0085	0.0085	CcSEcCtD
Dextroamphetamine—Cerebrovascular accident—Bleomycin—lymphatic system cancer	0.00849	0.00849	CcSEcCtD
Dextroamphetamine—Anorexia—Mechlorethamine—lymphatic system cancer	0.0082	0.0082	CcSEcCtD
Dextroamphetamine—Injury—Carmustine—lymphatic system cancer	0.0079	0.0079	CcSEcCtD
Dextroamphetamine—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00748	0.00748	CcSEcCtD
Dextroamphetamine—Erythema multiforme—Fludarabine—lymphatic system cancer	0.00742	0.00742	CcSEcCtD
Dextroamphetamine—Agitation—Teniposide—lymphatic system cancer	0.00715	0.00715	CcSEcCtD
Dextroamphetamine—Hypertension—Teniposide—lymphatic system cancer	0.00671	0.00671	CcSEcCtD
Dextroamphetamine—Chest pain—Teniposide—lymphatic system cancer	0.00662	0.00662	CcSEcCtD
Dextroamphetamine—Weight decreased—Bleomycin—lymphatic system cancer	0.00651	0.00651	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00634	0.00634	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Bleomycin—lymphatic system cancer	0.00632	0.00632	CcSEcCtD
Dextroamphetamine—Infection—Teniposide—lymphatic system cancer	0.0063	0.0063	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Bleomycin—lymphatic system cancer	0.00628	0.00628	CcSEcCtD
Dextroamphetamine—Agitation—Fludarabine—lymphatic system cancer	0.00628	0.00628	CcSEcCtD
Dextroamphetamine—Tachycardia—Teniposide—lymphatic system cancer	0.00619	0.00619	CcSEcCtD
Dextroamphetamine—Abdominal pain upper—Mitoxantrone—lymphatic system cancer	0.00617	0.00617	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00613	0.00613	CcSEcCtD
Dextroamphetamine—Anorexia—Teniposide—lymphatic system cancer	0.00605	0.00605	CcSEcCtD
Dextroamphetamine—Convulsion—Fludarabine—lymphatic system cancer	0.00592	0.00592	CcSEcCtD
Dextroamphetamine—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00589	0.00589	CcSEcCtD
Dextroamphetamine—Dyspnoea—Teniposide—lymphatic system cancer	0.00566	0.00566	CcSEcCtD
Dextroamphetamine—Depression—Carmustine—lymphatic system cancer	0.00558	0.00558	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00558	0.00558	CcSEcCtD
Dextroamphetamine—Infection—Fludarabine—lymphatic system cancer	0.00554	0.00554	CcSEcCtD
Dextroamphetamine—Erectile dysfunction—Vincristine—lymphatic system cancer	0.00552	0.00552	CcSEcCtD
Dextroamphetamine—Decreased appetite—Teniposide—lymphatic system cancer	0.00552	0.00552	CcSEcCtD
Dextroamphetamine—Vomiting—Mechlorethamine—lymphatic system cancer	0.00547	0.00547	CcSEcCtD
Dextroamphetamine—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.00547	0.00547	CcSEcCtD
Dextroamphetamine—Urinary tract infection—Carmustine—lymphatic system cancer	0.00544	0.00544	CcSEcCtD
Dextroamphetamine—Rash—Mechlorethamine—lymphatic system cancer	0.00543	0.00543	CcSEcCtD
Dextroamphetamine—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00542	0.00542	CcSEcCtD
Dextroamphetamine—Weight decreased—Vincristine—lymphatic system cancer	0.00542	0.00542	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00539	0.00539	CcSEcCtD
Dextroamphetamine—Speech disorder—Methotrexate—lymphatic system cancer	0.00539	0.00539	CcSEcCtD
Dextroamphetamine—Erectile dysfunction—Mitoxantrone—lymphatic system cancer	0.00537	0.00537	CcSEcCtD
Dextroamphetamine—Depression—Vincristine—lymphatic system cancer	0.00533	0.00533	CcSEcCtD
Dextroamphetamine—Anorexia—Fludarabine—lymphatic system cancer	0.00532	0.00532	CcSEcCtD
Dextroamphetamine—Weight decreased—Mitoxantrone—lymphatic system cancer	0.00528	0.00528	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Vincristine—lymphatic system cancer	0.00527	0.00527	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Vincristine—lymphatic system cancer	0.00524	0.00524	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00519	0.00519	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.00513	0.00513	CcSEcCtD
Dextroamphetamine—Sweating—Vincristine—lymphatic system cancer	0.00512	0.00512	CcSEcCtD
Dextroamphetamine—Nausea—Mechlorethamine—lymphatic system cancer	0.00511	0.00511	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.0051	0.0051	CcSEcCtD
Dextroamphetamine—Urinary tract infection—Mitoxantrone—lymphatic system cancer	0.00506	0.00506	CcSEcCtD
Dextroamphetamine—Urticaria—Teniposide—lymphatic system cancer	0.00504	0.00504	CcSEcCtD
Dextroamphetamine—Abdominal pain—Teniposide—lymphatic system cancer	0.00502	0.00502	CcSEcCtD
Dextroamphetamine—Body temperature increased—Teniposide—lymphatic system cancer	0.00502	0.00502	CcSEcCtD
Dextroamphetamine—Sweating—Mitoxantrone—lymphatic system cancer	0.00499	0.00499	CcSEcCtD
Dextroamphetamine—Dyspnoea—Fludarabine—lymphatic system cancer	0.00497	0.00497	CcSEcCtD
Dextroamphetamine—Dyspepsia—Fludarabine—lymphatic system cancer	0.00491	0.00491	CcSEcCtD
Dextroamphetamine—Decreased appetite—Fludarabine—lymphatic system cancer	0.00485	0.00485	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00481	0.00481	CcSEcCtD
Dextroamphetamine—Fatigue—Fludarabine—lymphatic system cancer	0.00481	0.00481	CcSEcCtD
Dextroamphetamine—Constipation—Fludarabine—lymphatic system cancer	0.00477	0.00477	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Teniposide—lymphatic system cancer	0.00468	0.00468	CcSEcCtD
Dextroamphetamine—Asthenia—Teniposide—lymphatic system cancer	0.00455	0.00455	CcSEcCtD
Dextroamphetamine—Body temperature increased—Fludarabine—lymphatic system cancer	0.00441	0.00441	CcSEcCtD
Dextroamphetamine—Diarrhoea—Teniposide—lymphatic system cancer	0.00434	0.00434	CcSEcCtD
Dextroamphetamine—Chest pain—Bleomycin—lymphatic system cancer	0.00427	0.00427	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00411	0.00411	CcSEcCtD
Dextroamphetamine—Tremor—Carmustine—lymphatic system cancer	0.0041	0.0041	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00409	0.00409	CcSEcCtD
Dextroamphetamine—Infection—Bleomycin—lymphatic system cancer	0.00406	0.00406	CcSEcCtD
Dextroamphetamine—Vomiting—Teniposide—lymphatic system cancer	0.00403	0.00403	CcSEcCtD
Dextroamphetamine—Agitation—Carmustine—lymphatic system cancer	0.00402	0.00402	CcSEcCtD
Dextroamphetamine—Asthenia—Fludarabine—lymphatic system cancer	0.004	0.004	CcSEcCtD
Dextroamphetamine—Rash—Teniposide—lymphatic system cancer	0.004	0.004	CcSEcCtD
Dextroamphetamine—Dermatitis—Teniposide—lymphatic system cancer	0.004	0.004	CcSEcCtD
Dextroamphetamine—Headache—Teniposide—lymphatic system cancer	0.00398	0.00398	CcSEcCtD
Dextroamphetamine—Anorexia—Bleomycin—lymphatic system cancer	0.0039	0.0039	CcSEcCtD
Dextroamphetamine—Agitation—Vincristine—lymphatic system cancer	0.00384	0.00384	CcSEcCtD
Dextroamphetamine—Diarrhoea—Fludarabine—lymphatic system cancer	0.00382	0.00382	CcSEcCtD
Dextroamphetamine—Convulsion—Carmustine—lymphatic system cancer	0.00379	0.00379	CcSEcCtD
Dextroamphetamine—Hypertension—Carmustine—lymphatic system cancer	0.00378	0.00378	CcSEcCtD
Dextroamphetamine—Nausea—Teniposide—lymphatic system cancer	0.00377	0.00377	CcSEcCtD
Dextroamphetamine—Chest pain—Carmustine—lymphatic system cancer	0.00372	0.00372	CcSEcCtD
Dextroamphetamine—Anxiety—Carmustine—lymphatic system cancer	0.00371	0.00371	CcSEcCtD
Dextroamphetamine—Dyspnoea—Bleomycin—lymphatic system cancer	0.00365	0.00365	CcSEcCtD
Dextroamphetamine—Convulsion—Vincristine—lymphatic system cancer	0.00362	0.00362	CcSEcCtD
Dextroamphetamine—Hypertension—Vincristine—lymphatic system cancer	0.0036	0.0036	CcSEcCtD
Dextroamphetamine—Decreased appetite—Bleomycin—lymphatic system cancer	0.00355	0.00355	CcSEcCtD
Dextroamphetamine—Infection—Carmustine—lymphatic system cancer	0.00355	0.00355	CcSEcCtD
Dextroamphetamine—Vomiting—Fludarabine—lymphatic system cancer	0.00355	0.00355	CcSEcCtD
Dextroamphetamine—Convulsion—Mitoxantrone—lymphatic system cancer	0.00352	0.00352	CcSEcCtD
Dextroamphetamine—Rash—Fludarabine—lymphatic system cancer	0.00352	0.00352	CcSEcCtD
Dextroamphetamine—Dermatitis—Fludarabine—lymphatic system cancer	0.00351	0.00351	CcSEcCtD
Dextroamphetamine—Hypertension—Mitoxantrone—lymphatic system cancer	0.00351	0.00351	CcSEcCtD
Dextroamphetamine—Headache—Fludarabine—lymphatic system cancer	0.00349	0.00349	CcSEcCtD
Dextroamphetamine—Tachycardia—Carmustine—lymphatic system cancer	0.00348	0.00348	CcSEcCtD
Dextroamphetamine—Chest pain—Mitoxantrone—lymphatic system cancer	0.00346	0.00346	CcSEcCtD
Dextroamphetamine—Anxiety—Mitoxantrone—lymphatic system cancer	0.00345	0.00345	CcSEcCtD
Dextroamphetamine—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.00343	0.00343	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00341	0.00341	CcSEcCtD
Dextroamphetamine—Anorexia—Carmustine—lymphatic system cancer	0.0034	0.0034	CcSEcCtD
Dextroamphetamine—Infection—Vincristine—lymphatic system cancer	0.00338	0.00338	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00332	0.00332	CcSEcCtD
Dextroamphetamine—Nausea—Fludarabine—lymphatic system cancer	0.00331	0.00331	CcSEcCtD
Dextroamphetamine—Infection—Mitoxantrone—lymphatic system cancer	0.0033	0.0033	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00329	0.00329	CcSEcCtD
Dextroamphetamine—Urticaria—Bleomycin—lymphatic system cancer	0.00325	0.00325	CcSEcCtD
Dextroamphetamine—Anorexia—Vincristine—lymphatic system cancer	0.00325	0.00325	CcSEcCtD
Dextroamphetamine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00324	0.00324	CcSEcCtD
Dextroamphetamine—Body temperature increased—Bleomycin—lymphatic system cancer	0.00323	0.00323	CcSEcCtD
Dextroamphetamine—Insomnia—Carmustine—lymphatic system cancer	0.00323	0.00323	CcSEcCtD
Dextroamphetamine—Irritability—Methotrexate—lymphatic system cancer	0.00321	0.00321	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00321	0.00321	CcSEcCtD
Dextroamphetamine—Mood swings—Methotrexate—lymphatic system cancer	0.00319	0.00319	CcSEcCtD
Dextroamphetamine—Dyspnoea—Carmustine—lymphatic system cancer	0.00318	0.00318	CcSEcCtD
Dextroamphetamine—Somnolence—Carmustine—lymphatic system cancer	0.00317	0.00317	CcSEcCtD
Dextroamphetamine—Anorexia—Mitoxantrone—lymphatic system cancer	0.00316	0.00316	CcSEcCtD
Dextroamphetamine—Decreased appetite—Carmustine—lymphatic system cancer	0.0031	0.0031	CcSEcCtD
Dextroamphetamine—Insomnia—Vincristine—lymphatic system cancer	0.00308	0.00308	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00308	0.00308	CcSEcCtD
Dextroamphetamine—Constipation—Carmustine—lymphatic system cancer	0.00305	0.00305	CcSEcCtD
Dextroamphetamine—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.00303	0.00303	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00301	0.00301	CcSEcCtD
Dextroamphetamine—Decreased appetite—Vincristine—lymphatic system cancer	0.00296	0.00296	CcSEcCtD
Dextroamphetamine—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00296	0.00296	CcSEcCtD
Dextroamphetamine—Somnolence—Mitoxantrone—lymphatic system cancer	0.00295	0.00295	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00294	0.00294	CcSEcCtD
Dextroamphetamine—Fatigue—Vincristine—lymphatic system cancer	0.00294	0.00294	CcSEcCtD
Dextroamphetamine—Asthenia—Bleomycin—lymphatic system cancer	0.00293	0.00293	CcSEcCtD
Dextroamphetamine—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00292	0.00292	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00292	0.00292	CcSEcCtD
Dextroamphetamine—Constipation—Vincristine—lymphatic system cancer	0.00291	0.00291	CcSEcCtD
Dextroamphetamine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00288	0.00288	CcSEcCtD
Dextroamphetamine—Fatigue—Mitoxantrone—lymphatic system cancer	0.00286	0.00286	CcSEcCtD
Dextroamphetamine—Constipation—Mitoxantrone—lymphatic system cancer	0.00284	0.00284	CcSEcCtD
Dextroamphetamine—Abdominal pain—Carmustine—lymphatic system cancer	0.00282	0.00282	CcSEcCtD
Dextroamphetamine—Body temperature increased—Carmustine—lymphatic system cancer	0.00282	0.00282	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00279	0.00279	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00271	0.00271	CcSEcCtD
Dextroamphetamine—Abdominal pain—Vincristine—lymphatic system cancer	0.00269	0.00269	CcSEcCtD
Dextroamphetamine—Body temperature increased—Vincristine—lymphatic system cancer	0.00269	0.00269	CcSEcCtD
Dextroamphetamine—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.00268	0.00268	CcSEcCtD
Dextroamphetamine—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.00265	0.00265	CcSEcCtD
Dextroamphetamine—Urticaria—Mitoxantrone—lymphatic system cancer	0.00264	0.00264	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Carmustine—lymphatic system cancer	0.00263	0.00263	CcSEcCtD
Dextroamphetamine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00262	0.00262	CcSEcCtD
Dextroamphetamine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00262	0.00262	CcSEcCtD
Dextroamphetamine—Vomiting—Bleomycin—lymphatic system cancer	0.0026	0.0026	CcSEcCtD
Dextroamphetamine—Depression—Methotrexate—lymphatic system cancer	0.00258	0.00258	CcSEcCtD
Dextroamphetamine—Rash—Bleomycin—lymphatic system cancer	0.00258	0.00258	CcSEcCtD
Dextroamphetamine—Dermatitis—Bleomycin—lymphatic system cancer	0.00258	0.00258	CcSEcCtD
Dextroamphetamine—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.00257	0.00257	CcSEcCtD
Dextroamphetamine—Asthenia—Carmustine—lymphatic system cancer	0.00256	0.00256	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Vincristine—lymphatic system cancer	0.00251	0.00251	CcSEcCtD
Dextroamphetamine—Sweating—Methotrexate—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00244	0.00244	CcSEcCtD
Dextroamphetamine—Asthenia—Vincristine—lymphatic system cancer	0.00244	0.00244	CcSEcCtD
Dextroamphetamine—Diarrhoea—Carmustine—lymphatic system cancer	0.00244	0.00244	CcSEcCtD
Dextroamphetamine—Nausea—Bleomycin—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Dextroamphetamine—Asthenia—Mitoxantrone—lymphatic system cancer	0.00238	0.00238	CcSEcCtD
Dextroamphetamine—Dizziness—Carmustine—lymphatic system cancer	0.00236	0.00236	CcSEcCtD
Dextroamphetamine—Diarrhoea—Vincristine—lymphatic system cancer	0.00233	0.00233	CcSEcCtD
Dextroamphetamine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00227	0.00227	CcSEcCtD
Dextroamphetamine—Vomiting—Carmustine—lymphatic system cancer	0.00227	0.00227	CcSEcCtD
Dextroamphetamine—Dizziness—Vincristine—lymphatic system cancer	0.00225	0.00225	CcSEcCtD
Dextroamphetamine—Rash—Carmustine—lymphatic system cancer	0.00225	0.00225	CcSEcCtD
Dextroamphetamine—Dermatitis—Carmustine—lymphatic system cancer	0.00225	0.00225	CcSEcCtD
Dextroamphetamine—Headache—Carmustine—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
Dextroamphetamine—Erythema multiforme—Methotrexate—lymphatic system cancer	0.0022	0.0022	CcSEcCtD
Dextroamphetamine—Vomiting—Vincristine—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
Dextroamphetamine—Rash—Vincristine—lymphatic system cancer	0.00215	0.00215	CcSEcCtD
Dextroamphetamine—Dermatitis—Vincristine—lymphatic system cancer	0.00215	0.00215	CcSEcCtD
Dextroamphetamine—Headache—Vincristine—lymphatic system cancer	0.00213	0.00213	CcSEcCtD
Dextroamphetamine—Nausea—Carmustine—lymphatic system cancer	0.00212	0.00212	CcSEcCtD
Dextroamphetamine—Vomiting—Mitoxantrone—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Dextroamphetamine—Rash—Mitoxantrone—lymphatic system cancer	0.00209	0.00209	CcSEcCtD
Dextroamphetamine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00209	0.00209	CcSEcCtD
Dextroamphetamine—Headache—Mitoxantrone—lymphatic system cancer	0.00208	0.00208	CcSEcCtD
Dextroamphetamine—Nausea—Vincristine—lymphatic system cancer	0.00202	0.00202	CcSEcCtD
Dextroamphetamine—Nausea—Mitoxantrone—lymphatic system cancer	0.00197	0.00197	CcSEcCtD
Dextroamphetamine—Convulsion—Methotrexate—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Dextroamphetamine—Chest pain—Methotrexate—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Dextroamphetamine—Infection—Methotrexate—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Dextroamphetamine—Anorexia—Methotrexate—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Dextroamphetamine—Insomnia—Methotrexate—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Dextroamphetamine—Dyspnoea—Methotrexate—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Dextroamphetamine—Somnolence—Methotrexate—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Dextroamphetamine—Dyspepsia—Methotrexate—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Dextroamphetamine—Decreased appetite—Methotrexate—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Dextroamphetamine—Fatigue—Methotrexate—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Dextroamphetamine—Urticaria—Methotrexate—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Dextroamphetamine—Abdominal pain—Methotrexate—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Dextroamphetamine—Body temperature increased—Methotrexate—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Dextroamphetamine—Asthenia—Methotrexate—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Dextroamphetamine—Diarrhoea—Methotrexate—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Dextroamphetamine—Dizziness—Methotrexate—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Dextroamphetamine—Vomiting—Methotrexate—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Dextroamphetamine—Rash—Methotrexate—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Dextroamphetamine—Dermatitis—Methotrexate—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Dextroamphetamine—Headache—Methotrexate—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Dextroamphetamine—Nausea—Methotrexate—lymphatic system cancer	0.000982	0.000982	CcSEcCtD
